Given that NF-κB is elevated in AD, PD, and ASD patients, aberrant or varying levels of butyrate in patients with gut dysbiosis may indirectly lead to dysregulation of NF-κB expression, leading to increased neuroinflammation in these patients [95]. The gene discussed is NFKB1; the disease is Alzheimer disease.